Kentucky 2023 2023 Regular Session

Kentucky House Bill HB276 Introduced / Bill

                    UNOFFICIAL COPY  	23 RS BR 156 
Page 1 of 4 
XXXX   2/14/2023 11:40 AM  	Jacketed 
AN ACT relating to reproductive health care. 1 
Be it enacted by the General Assembly of the Commonwealth of Kentucky: 2 
Section 1.   KRS 205.592 is amended to read as follows: 3 
Pregnant women[,] and new mothers up to twelve (12) months postpartum, regardless of 4 
citizenship or national origin, and children up to age one (1) shall be eligible for 5 
participation in the Kentucky Medical Assistance Program if: 6 
(1) They have family income up to but not exceeding one hundred and eighty-five 7 
percent (185%) of the nonfarm income official poverty guidelines as promulgated 8 
by the Department of Health and Human Services of the United States as revised 9 
annually; and 10 
(2) They are otherwise eligible for the program. 11 
SECTION 2.   A NEW SECTION OF KRS CHAPTER 205 IS CREATED TO 12 
READ AS FOLLOWS: 13 
(1) As used in this section, unless the context requires otherwise: 14 
(a) "Eligible individual" means an individual who:  15 
1. Is not pregnant; 16 
2. Has a family combined income up to, but not exceeding, two hundred 17 
sixty percent (260%) of the nonfarm income official poverty guidelines 18 
as promulgated by the United States Department of Health and 19 
Human Services; and 20 
3. a. Is eligible for the Kentucky Medical Assistance Program; or 21 
b. Would otherwise be eligible for the Kentucky Medical Assistance 22 
Program, except that the individual is not a citizen of the United 23 
States and is not considered an eligible noncitizen pursuant to 8 24 
U.S.C. sec. 1611 or 1612; 25 
(b) "Family planning services" means all the following services, regardless of 26 
an individual’s age, sex, or gender identity, or the age, sex, or gender 27  UNOFFICIAL COPY  	23 RS BR 156 
Page 2 of 4 
XXXX   2/14/2023 11:40 AM  	Jacketed 
identity of the individual’s partner, including but not limited to: 1 
1. All contraceptive drugs, devices, and other products approved by the 2 
United States Food and Drug Administration, including: 3 
a. Over-the-counter contraceptive drugs, devices, and products; 4 
and 5 
b. A twelve (12) month supply of self-administered contraceptive 6 
drugs, devices, and supplies, unless the individual requests a 7 
smaller supply or the prescribing provider restricts the enrollee 8 
to a smaller supply; 9 
2. Voluntary sterilization procedures; 10 
3. Activities that enable individuals to determine the number and spacing 11 
of their children and to select the means by which this may be 12 
achieved; 13 
4. The consultations, examinations, and medical services that are 14 
necessary to prescribe, dispense, insert, deliver, distribute, administer, 15 
or remove contraceptive drugs, devices, and other products; and 16 
5. Follow-up visits to evaluate or manage problems associated with 17 
contraceptive drugs, devices, or products; and 18 
(c) "Family planning-related services" means educational, medical, and social 19 
services, including but not limited to: 20 
1. Medically necessary evaluations or preventive services such as tobacco 21 
utilization screening, counseling, testing, and cessation services; 22 
2. Cervical cancer screening and prevention; 23 
3. Diagnosis of treatment of a sexually transmitted infection and 24 
medication and supplies to prevent a sexually transmitted infection; 25 
and 26 
4. Any other medical diagnosis, treatment, or preventive service that is 27  UNOFFICIAL COPY  	23 RS BR 156 
Page 3 of 4 
XXXX   2/14/2023 11:40 AM  	Jacketed 
routinely provided as part of a family planning visit. 1 
(2) The Cabinet for Health and Family Services shall establish a family planning 2 
program within the Department for Medicaid Services to provide family planning 3 
services and family planning-related services to eligible individuals. 4 
(3) In administering this program, the cabinet shall not: 5 
(a) Infringe upon an eligible individual’s choice of contraceptive drug, device, 6 
or product by requiring prior authorization, step therapy, or other 7 
utilization control techniques for medically appropriate contraceptive drugs, 8 
devices, or products approved by the United States Food and Drug 9 
Administration; 10 
(b) Impose any cost-sharing requirements for enrolled individuals; or 11 
(c) Deny coverage based on the sex, sexual orientation, or gender identity of 12 
the eligible individual, or the sex, sexual orientation, or gender identity of 13 
the eligible individual’s partner. 14 
(4) The Department for Medicaid Services shall: 15 
(a) Promulgate administrative regulations in accordance with KRS Chapter 16 
13A, and amend any contract with a managed care organization as is 17 
necessary, to implement this section; and 18 
(b) Collaborate with the Division of Health Benefit Exchange within the 19 
cabinet, health care consumer advocates, family planning providers, and 20 
other interested stakeholders to establish a comprehensive community 21 
education and outreach campaign to provide culturally and linguistically 22 
accessible information to facilitate participation in the program, including 23 
but not limited to enrollment procedures, program services, and benefit 24 
utilization. 25 
Section 3.   If the Cabinet for Health and Family Services or the Department for 26 
Medicaid Services determines that a waiver or any other authorization from a federal 27  UNOFFICIAL COPY  	23 RS BR 156 
Page 4 of 4 
XXXX   2/14/2023 11:40 AM  	Jacketed 
agency is necessary prior to the implementation of any provision of Sections 1 and 2 of 1 
this Act, the cabinet or department shall, within 90 days after the effective date of this 2 
Act, request the waiver or authorization and shall only delay full implementation of those 3 
provisions for which a waiver or authorization was deemed necessary until the waiver or 4 
authorization is granted. 5